Vimarsana
Biggest News Aggregation in the World

Velosity Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Velosity Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Velosity Capital Today - Breaking & Trending Today

Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines - Vimarsana News

Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines

SAN DIEGO--(BUSINESS WIRE)--Apr 24, 2024--

Endeavor BioMedicines Raises $132.5M in Series C Financing - Vimarsana News

Endeavor BioMedicines Raises $132.5M in Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Diagonal Therapeutics Launches with $128 Million in Financing - Vimarsana News

Diagonal Therapeutics Launches with $128 Million in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Diagonal starts up with $128M to make better 'activator' antibody drugs - Vimarsana News

Diagonal starts up with $128M to make better 'activator' antibody drugs

BioPharma

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round - Vimarsana News

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round

The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...